{"id":359,"date":"2015-01-14T10:16:56","date_gmt":"2015-01-14T10:16:56","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=359"},"modified":"2021-07-24T12:56:24","modified_gmt":"2021-07-24T07:26:24","slug":"delveinsights-gene-therapy-reports-launched","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched","title":{"rendered":"DelveInsight\u2019s Gene Therapy Reports: Launched"},"content":{"rendered":"<blockquote>\n<h3 style=\"text-align:center;\"><span style=\"color:#993366;\">Immense Growth Potential in the Gene Therapy Market!<\/span><\/h3>\n<\/blockquote>\n<p style=\"text-align:justify;\"><strong><span style=\"color:#666699;\">DelveInsight has launched its Gene Therapy Report: \u201c<em>Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape<\/em>\u201d. These Reports are the outcome of very best analytical abilities and diligent market research amalgamated with opinions of gene therapy industry experts. The report uncovers the potential of global Gene Therapy Market with insights into 15 Therapy Areas with collective pipeline of more than 300 gene therapies and the companies at their forefront.<\/span><\/strong><\/p>\n<h3><span style=\"color:#189696;\">Report Summary<\/span><\/h3>\n<p style=\"text-align:justify;\"><span style=\"color:#666699;\">These reports provide information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Report provides the gene therapy targets which are close to 190 with the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety DelveInsight Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.<\/span><\/p>\n<h3><span style=\"color:#189696;\">Report Highlights<\/span><\/h3>\n<ul>\n<li style=\"text-align:justify;\"><span style=\"color:#666699;\">Global Gene Therapy Market &amp; Pipeline Insight.<\/span><\/li>\n<li style=\"text-align:justify;\"><span style=\"color:#666699;\">Trends in gene therapy partnering deals.<\/span><\/li>\n<li style=\"text-align:justify;\"><span style=\"color:#666699;\">Current Prominent Research Areas and Key Players.<\/span><\/li>\n<li style=\"text-align:justify;\"><span style=\"color:#666699;\">Companies Targeting Prominent Therapeutic Areas.<\/span><\/li>\n<li style=\"text-align:justify;\"><span style=\"color:#666699;\">Number of Gene Therapies in Clinical Trials.<\/span><\/li>\n<li style=\"text-align:justify;\"><span style=\"color:#666699;\">Number of Gene Therapies by Vectors used.<\/span><\/li>\n<li style=\"text-align:justify;\"><span style=\"color:#666699;\">Technology and their innovative Companies.<\/span><\/li>\n<li style=\"text-align:justify;\"><span style=\"color:#666699;\">Early Market Winners for Gene Therapy.<\/span><\/li>\n<\/ul>\n<p><a href=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/01\/scope-e1421230463281.jpg\"><img decoding=\"async\" class=\"  wp-image-361 aligncenter\" src=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/01\/scope-e1421230463281.jpg\" alt=\"Scope\" width=\"711\" height=\"329\" srcset=\"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/01\/scope-e1421230463281.jpg 1627w, https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/01\/scope-e1421230463281-300x139.jpg 300w, https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/01\/scope-e1421230463281-768x356.jpg 768w, https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/01\/scope-e1421230463281-1024x475.jpg 1024w\" sizes=\"(max-width: 711px) 100vw, 711px\" \/><\/a><\/p>\n<p><a href=\"https:\/\/delveinsightblog.wordpress.com\/2015\/01\/14\/delveinsights-gene-therapy-reports-launched\/reasons-to-buy\/\" rel=\"attachment wp-att-360\"><img decoding=\"async\" class=\"aligncenter  wp-image-360\" src=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/01\/reasons-to-buy.jpg\" alt=\"Reasons to buy\" width=\"712\" height=\"432\" srcset=\"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/01\/reasons-to-buy.jpg 1603w, https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/01\/reasons-to-buy-300x182.jpg 300w, https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/01\/reasons-to-buy-768x466.jpg 768w, https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/01\/reasons-to-buy-1024x622.jpg 1024w\" sizes=\"(max-width: 712px) 100vw, 712px\" \/><\/a><\/p>\n<p style=\"text-align:justify;\"><span style=\"color:#189696;\">The Report insight covers therapy areas like;<\/span> <em><span style=\"color:#ff0000;\">Oncology, Central nervous system, Genetic Disorders, Hematological disorders, Metabolic disorders, Ophthalmology, Cardiovascular disease, Respiratory, Immunology<\/span> <\/em><span style=\"color:#189696;\">and other therapy areas.<\/span><\/p>\n<p style=\"text-align:justify;\"><span style=\"color:#189696;\">For more information on Gene Therapy reports for various therapeutic areas contact us at<\/span> <span style=\"text-decoration:underline;\"><span style=\"color:#0000ff;text-decoration:underline;\"><a style=\"color:#0000ff;text-decoration:underline;\" href=\"mailto:info@delveinsight.com\"><strong>info@delveinsight.com<\/strong><\/a><\/span><\/span>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immense Growth Potential in the Gene Therapy Market! DelveInsight has launched its Gene Therapy Report: \u201cGene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape\u201d. These Reports are the outcome of very best analytical abilities and diligent market research amalgamated with opinions of gene therapy industry experts. The report uncovers the potential of global [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[143,158,180,205,209,263,282,314,385,397,427,434,17246,513,557],"industry":[17225],"therapeutic_areas":[17235],"class_list":["post-359","post","type-post","status-publish","format-standard","hentry","category-articles","tag-cardiovascular-disease","tag-central-nervous-system","tag-competitive-landscape","tag-delveinsight-competitive-matrix","tag-delveinsights-gene-therapy-reports","tag-genetic-disorders","tag-hematological-disorders","tag-immunology","tag-market-trend","tag-metabolic-disorders","tag-oncology","tag-ophthalmology","tag-pipeline-assessment","tag-respiratory","tag-technology","industry-pharmaceutical","therapeutic_areas-cell-and-gene-therapy"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Gene Therapy Market Analysis Reports | DelveInsight<\/title>\n<meta name=\"description\" content=\"DelveInsight has launched its Gene Therapy Report: \u201cGene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape\u201d.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gene Therapy Market Analysis Reports | DelveInsight\" \/>\n<meta property=\"og:description\" content=\"DelveInsight has launched its Gene Therapy Report: \u201cGene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape\u201d.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-01-14T10:16:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-24T07:26:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/01\/scope-e1421230463281.jpg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gene Therapy Market Analysis Reports | DelveInsight","description":"DelveInsight has launched its Gene Therapy Report: \u201cGene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape\u201d.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched","og_locale":"en_US","og_type":"article","og_title":"Gene Therapy Market Analysis Reports | DelveInsight","og_description":"DelveInsight has launched its Gene Therapy Report: \u201cGene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape\u201d.","og_url":"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2015-01-14T10:16:56+00:00","article_modified_time":"2021-07-24T07:26:24+00:00","og_image":[{"url":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/01\/scope-e1421230463281.jpg","type":"","width":"","height":""}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched","url":"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched","name":"Gene Therapy Market Analysis Reports | DelveInsight","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched#primaryimage"},"thumbnailUrl":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/01\/scope-e1421230463281.jpg","datePublished":"2015-01-14T10:16:56+00:00","dateModified":"2021-07-24T07:26:24+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"DelveInsight has launched its Gene Therapy Report: \u201cGene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape\u201d.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-gene-therapy-reports-launched#primaryimage","url":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/01\/scope-e1421230463281.jpg","contentUrl":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/01\/scope-e1421230463281.jpg"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Cardiovascular disease<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Central nervous system<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Competitive landscape<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight Competitive Matrix<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight&#039;s Gene Therapy Reports<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Genetic Disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Hematological disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Immunology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Market Trend<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Metabolic disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Oncology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Ophthalmology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">pipeline Assessment<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Respiratory<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Technology<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Cardiovascular disease<\/span>","<span class=\"advgb-post-tax-term\">Central nervous system<\/span>","<span class=\"advgb-post-tax-term\">Competitive landscape<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight Competitive Matrix<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight&#039;s Gene Therapy Reports<\/span>","<span class=\"advgb-post-tax-term\">Genetic Disorders<\/span>","<span class=\"advgb-post-tax-term\">Hematological disorders<\/span>","<span class=\"advgb-post-tax-term\">Immunology<\/span>","<span class=\"advgb-post-tax-term\">Market Trend<\/span>","<span class=\"advgb-post-tax-term\">Metabolic disorders<\/span>","<span class=\"advgb-post-tax-term\">Oncology<\/span>","<span class=\"advgb-post-tax-term\">Ophthalmology<\/span>","<span class=\"advgb-post-tax-term\">pipeline Assessment<\/span>","<span class=\"advgb-post-tax-term\">Respiratory<\/span>","<span class=\"advgb-post-tax-term\">Technology<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Jan 14, 2015","modified":"Updated on Jul 24, 2021"},"absolute_dates_time":{"created":"Posted on Jan 14, 2015 10:16 am","modified":"Updated on Jul 24, 2021 12:56 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=359"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/359\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=359"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=359"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}